| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2862634 | American Journal of Hypertension | 2007 | 7 Pages |
Abstract
Compared with metoprolol, carvedilol significantly improves endothelial function in patients with T2DM. Changes in glycemic control and oxidative stress do not seem to explain the observed improvements in FMD, which suggests that other mechanisms may be involved.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Alan J. Bank, Aaron S. Kelly, Andrea M. Thelen, Daniel R. Kaiser, J. Michael Gonzalez-Campoy,